TY - JOUR
T1 - Hydroethanolic extract of lampaya medicinalis phil. (verbenaceae) decreases proinflammatory marker expression in palmitic acid-exposed macrophages
AU - Ormazabal, Paulina
AU - Cifuentes, Mariana
AU - Varì, Rosaria
AU - Scazzocchio, Beatrice
AU - Masella, Roberta
AU - Pacheco, Igor
AU - Vega, Wladimir
AU - Paredes, Adrián
AU - Morales, Glauco
N1 - Publisher Copyright:
© 2020 Bentham Science Publishers.
PY - 2020
Y1 - 2020
N2 - Background: Obesity is a major health problem associated with increased comorbidities, which are partially triggered by inflammation. Proinflammatory macrophage infiltration in adipose tissue of individuals with obesity increases chronic inflammation. Obesity is associated with elevated plasma levels of saturated fatty acids, such as palmitic acid (PA), which promotes inflammation in vivo and in vitro. Infusions of Lampaya medicinalis Phil. (Verbenaceae) are used in the folk medicine of Northern Chile to counteract inflammation of rheumatic diseases. Hydroethanolic extract of lampaya (HEL) contains spectrophotometrically defined compounds that may contribute to the observed effect on inflammation. Methods: We evaluated the phytochemical composition of HEL by high-performance liquid chroma-tography coupled to diode array detection (HPLC-DAD) and liquid chromatography-electrospray ioni-zation-tandem mass spectrometry (LC-ESI-MS/MS). We assessed whether the exposure to HEL af-fects PA-induced expression of proinflammatory factors in THP-1 macrophages. Results: HPLC-DAD and LC-ESI-MS/MS analyses showed the presence of considerable amounts of flavonoids in HEL. The PA-induced phosphorylation of the inflammatory pathway mediators IKK and NF-κB, as well as the elevated expression and secretion of proinflammatory cytokines (IL-6, TNF-α), were reduced in cells pre-exposed to HEL. Conclusion: These findings give new insights about the effect of HEL reducing IKK/NF-κB proin-flammatory pathway, likely explained by the number of flavonoids contained in the extract. More studies would be needed to define the possible role of Lampaya as a preventive approach in subjects with obesity whose circulating PA might contribute to chronic inflammation.
AB - Background: Obesity is a major health problem associated with increased comorbidities, which are partially triggered by inflammation. Proinflammatory macrophage infiltration in adipose tissue of individuals with obesity increases chronic inflammation. Obesity is associated with elevated plasma levels of saturated fatty acids, such as palmitic acid (PA), which promotes inflammation in vivo and in vitro. Infusions of Lampaya medicinalis Phil. (Verbenaceae) are used in the folk medicine of Northern Chile to counteract inflammation of rheumatic diseases. Hydroethanolic extract of lampaya (HEL) contains spectrophotometrically defined compounds that may contribute to the observed effect on inflammation. Methods: We evaluated the phytochemical composition of HEL by high-performance liquid chroma-tography coupled to diode array detection (HPLC-DAD) and liquid chromatography-electrospray ioni-zation-tandem mass spectrometry (LC-ESI-MS/MS). We assessed whether the exposure to HEL af-fects PA-induced expression of proinflammatory factors in THP-1 macrophages. Results: HPLC-DAD and LC-ESI-MS/MS analyses showed the presence of considerable amounts of flavonoids in HEL. The PA-induced phosphorylation of the inflammatory pathway mediators IKK and NF-κB, as well as the elevated expression and secretion of proinflammatory cytokines (IL-6, TNF-α), were reduced in cells pre-exposed to HEL. Conclusion: These findings give new insights about the effect of HEL reducing IKK/NF-κB proin-flammatory pathway, likely explained by the number of flavonoids contained in the extract. More studies would be needed to define the possible role of Lampaya as a preventive approach in subjects with obesity whose circulating PA might contribute to chronic inflammation.
KW - Cytokines
KW - Hydroethanolic extract of Lampaya
KW - Inflammation
KW - Obesity
KW - Palmitic acid
KW - THP-1 macrophages
UR - http://www.scopus.com/inward/record.url?scp=85090683865&partnerID=8YFLogxK
U2 - 10.2174/1871530320666200513082300
DO - 10.2174/1871530320666200513082300
M3 - Article
C2 - 32400338
AN - SCOPUS:85090683865
SN - 1871-5303
VL - 20
SP - 1309
EP - 1320
JO - Endocrine, Metabolic and Immune Disorders - Drug Targets
JF - Endocrine, Metabolic and Immune Disorders - Drug Targets
IS - 8
ER -